Clinical Profile of Adenosine Deaminase and Age and Sex Related Variations in Pleural Effusion – A Study of 100 Cases


PDF PDF

Keywords

Adenosine Deaminase
Pleural Effusion
Tuberculosis
Age
Female Sex

How to Cite

1.
Clinical Profile of Adenosine Deaminase and Age and Sex Related Variations in Pleural Effusion – A Study of 100 Cases. The Insight [Internet]. 2026 Jan. 1 [cited 2026 Apr. 27];8(03):668-72. Available from: https://bdjournals.org/insight/article/view/830

Abstract

Background: Pleural effusion is a common clinical condition with varied etiologies. Adenosine Deaminase (ADA) has been recognized as a useful diagnostic biomarker, especially in differentiating tuberculous pleural effusion from other causes. However, the influence of patient age and sex on ADA levels remains an area of ongoing investigation. Objective: To study the profile of ADA levels in pleural effusion and assess the impact of age and female sex on ADA levels. Methods & Materials: This prospective observational study was conducted on 100 consecutive patients diagnosed with pleural effusion. ADA levels were estimated in pleural fluid. Patients were stratified according to age (<40 years vs. ≥40 years) and sex (male vs. female) for subgroup analysis. Clinical correlation with diagnosis was performed. Results: Mean ADA level was significantly higher in tuberculous pleural effusion (72.3 ± 15.2 U/L) compared to malignant (34.5 ± 10.6 U/L), parapneumonic (42.8 ± 11.5 U/L), and transudative effusions (18.6 ± 5.3 U/L) (p < 0.001). Younger patients (<40 years) had significantly higher ADA values (65.2 ± 20.4 U/L) compared to older patients (≥40 years, 49.8 ± 18.7 U/L; p = 0.01). Females demonstrated slightly higher ADA levels than males (58.9 ± 19.6 U/L vs. 53.4 ± 18.2 U/L; p = 0.04). Conclusion: ADA remains a reliable marker for tuberculous pleural effusion. Younger age and female sex were associated with relatively higher ADA levels, suggesting the need for cautious interpretation in these groups.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2026 The Insight